PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
150.33%
Net income growth under 50% of VET's 966.38%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-23.19%
Both reduce yoy D&A, with VET at -28.48%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-66.67%
Negative yoy deferred tax while VET stands at 2038.21%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
33.33%
SBC growth well above VET's 50.20%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-272.73%
Both reduce yoy usage, with VET at -601.06%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-16.08%
AR is negative yoy while VET is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-154.55%
Both reduce yoy usage, with VET at -601.06%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-48.72%
Both negative yoy, with VET at -3569.59%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
15.02%
Some CFO growth while VET is negative at -11.81%. John Neff would note a short-term liquidity lead over the competitor.
-2.04%
Both yoy lines negative, with VET at -39.18%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-95.00%
Negative yoy acquisition while VET stands at 91.85%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
122.58%
We have some outflow growth while VET is negative at -35.47%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
28.19%
We have mild expansions while VET is negative at -47.49%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-590.00%
We cut debt repayment yoy while VET is 1.32%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.